APD668 is potent GDIR Agonists, and it was developed as an oral drug candidate for the treatment of type 2 diabetes.
For research use only. We do not sell to patients.
Name | APD668 |
---|---|
Iupac Chemical Name | isopropyl 4-((1-(2-fluoro-4-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)oxy)piperidine-1-carboxylate |
Synonyms | APD668; APD-668; APD 668; JNJ-28630368; JNJ28630368; JNJ 28630368 |
Molecular Formula | C21H24FN5O5S |
Molecular Weight | 477.51 |
Smile | FC1=C(C=CC(=C1)S(=O)(=O)C)N1N=CC=2C1=NC=NC2OC2CCN(CC2)C(=O)OC(C)C |
InChiKey | XTRUQJBVQBUKSQ-UHFFFAOYSA-N |
InChi | InChI=1S/C21H24FN5O5S/c1-13(2)31-21(28)26-8-6-14(7-9-26)32-20-16-11-25-27(19(16)23-12-24-20)18-5-4-15(10-17(18)22)33(3,29)30/h4-5,10-14H,6-9H2,1-3H3 |
CAS Number | 832714-46-2 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Purity | 98% |
---|---|
Storage | 3 years -20ºCpowder |
Solubility | 2mg/ml in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |